ConvaTec Group PLC (LON:CTEC) Given Consensus Rating of “Moderate Buy” by Brokerages

ConvaTec Group PLC (LON:CTEC) has been given an average rating of “Moderate Buy” by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is GBX 308.78.

A number of research analysts recently issued reports on CTEC shares. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 340 price target on shares of ConvaTec Group in a report on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 315 price target on shares of ConvaTec Group in a report on Wednesday, April 8th. Stifel Nicolaus reaffirmed a “buy” rating and issued a GBX 315 price target on shares of ConvaTec Group in a report on Wednesday, March 11th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 325 price target on shares of ConvaTec Group in a report on Friday, May 15th. Finally, UBS Group reaffirmed a “buy” rating and issued a GBX 375 price target on shares of ConvaTec Group in a report on Monday, May 18th.

ConvaTec Group Stock Performance

ConvaTec Group stock opened at GBX 197 on Tuesday. The stock has a 50-day simple moving average of GBX 219.84 and a 200 day simple moving average of GBX 230.25. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 106.19. ConvaTec Group has a 12-month low of GBX 195.90 and a 12-month high of GBX 311.20. The stock has a market capitalization of £3.85 billion, a price-to-earnings ratio of 22.91, a P/E/G ratio of 0.93 and a beta of 0.78.

Insiders Place Their Bets

In other ConvaTec Group news, insider Jonny Mason sold 291,149 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of GBX 234, for a total transaction of £681,288.66. Corporate insiders own 0.95% of the company’s stock.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.